{"content":"<li class=\"n-box-item date-title\" data-end=\"1375761599\" data-start=\"1375675200\" data-txt=\"Friday, December 20, 2019\">Monday, August  5, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1194792\" data-ts=\"1375757107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194792-asia-broadly-lower-rba-in-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asia broadly lower, RBA in focus</a></h4><ul>     <li>Shares of Sony fall <font color='red'>5%</font> in Japan after the company's board <a href=\"https://seekingalpha.com/currents/post/1194732\" target=\"_blank\">categorically rejects</a> Dan Loeb's idea for an entertainment business spinoff. Also weighing on Japanese shares is the yen which, at &yen;97.96, is firmer by <font color='green'>0.35%</font> against the dollar. The Nikkei is down <font color='red'>1.5%</font>. <br>     </li>     <li>In Australia, the ASX slips <font color='red'>0.39%</font> and the aussie is steady ahead of an expected RBA&nbsp;rate cut.</li>     <li>Elsewhere in the region: The Hang Seng slides <font color='red'>1.83%</font> while the Shanghai Composite is off <font color='red'>0.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194792\" data-linked=\"Asia broadly lower, RBA in focus\" data-tweet=\"Asia broadly lower, RBA in focus https://seekingalpha.com/news/1194792-asia-broadly-lower-rba-in-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/1194792-asia-broadly-lower-rba-in-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194772\" data-ts=\"1375750242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOLX\" target=\"_blank\">HOLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194772-more-on-hologic-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Hologic earnings</a></h4><ul>\n<li>Hologic (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HOLX\" title=\"Hologic, Inc.\">HOLX</a>) <a href=\"https://seekingalpha.com/market_currents/post/1193582\" target=\"_blank\">FQ3 beats slightly</a> on the the bottom line but comes up a bit short on top.</li>\n<li>Net earnings swung to a loss on higher charges restructuring and acquisition-related costs as well as other one-time items.</li>\n<li>Looking forward, the company forecast FQ4 EPS of $0.36 to $0.37 on revenue of $615M to $625M, below Street estimates of $0.44 on $651M in revenue.</li>\n<li>For the year, it lowers its per-share earnings estimate to $1.46 to $ 1.47, from its previous estimate for $1.54 to $1.56, but affirms its revenue outlook. Shares <font color=\"red\">-2.7%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1194772\" data-linked=\"More on Hologic earnings\" data-tweet=\"$HOLX - More on Hologic earnings https://seekingalpha.com/news/1194772-more-on-hologic-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1194772-more-on-hologic-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194762\" data-ts=\"1375749494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLS\" target=\"_blank\">NLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194762-more-on-nautilus-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Nautilus earnings</a></h4><ul>\n<li>Nautilus (NYSE:<a href=\"https://seekingalpha.com/symbol/NLS\" title=\"Nautilus, Inc.\">NLS</a>) <a href=\"https://seekingalpha.com/market_currents/post/1194672\" target=\"_blank\">Q2 misses</a> across the board as the company was dealt with slowing sales and tough Y/Y comps in its retail business due to customers accelerating their normal buying pattern in anticipation of a price increase implement in Q3 last year.</li>\n<li>Net earnings swung to a profit on an income tax benefit, masking over an 8.4% decline in total revenue.</li>\n<li>Sales in the larger direct unit rose 2.5% to $25.3M, while sales in its retail business slipped 27% to $10.2M.</li>\n<li>Gross margin widened to 47.8% from 43.4%, as lower overhead costs helped to mitigate the sales slump.</li>\n<li>Shares <font color=\"red\">-11.5%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1194762\" data-linked=\"More on Nautilus earnings\" data-tweet=\"$NLS - More on Nautilus earnings https://seekingalpha.com/news/1194762-more-on-nautilus-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1194762-more-on-nautilus-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194682\" data-ts=\"1375741408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAA\" target=\"_blank\">PAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194682-profits-slide-at-plains-all-american-paa-natural-gas\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Profits slide at Plains All American, PAA Natural Gas</a></h4><ul>     <li>Plains All American's (NYSE:<a href='https://seekingalpha.com/symbol/PAA' title='Plains All American Pipeline, L.P.'>PAA</a>) <a href=\"https://seekingalpha.com/currents/post/1193752\" target=\"_blank\">Q2 earnings</a> tumbled 23% Y/Y, while gas-storage affiliate PAA Natural Gas Storage's (NYSE:<a href='https://seekingalpha.com/symbol/PNG' title='PAA Natural Gas Storage, L.P.'>PNG</a>) <a href=\"https://seekingalpha.com/currents/post/1193632\" target=\"_blank\">Q2 earnings</a> slipped 2.5% as the companies were hurt by higher operating costs.</li>     <li>At Plains, operating margin fell to 3.7% from 4.7%; operating expenses increased 6.3%; again raised its capital spending view for the year, to $1.6B from $1.4B.</li>     <li>At PAA&nbsp;Natural Gas, revenue from hub services and merchant storage, which includes natural gas sales, rose 22%; operating costs rose 18%.</li>     <li><a href='https://seekingalpha.com/symbol/PAA' title='Plains All American Pipeline, L.P.'>PAA</a> <font color='red'>-1.9%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194682\" data-linked=\"Profits slide at Plains All American, PAA Natural Gas\" data-tweet=\"$PAA $PAA $PNG - Profits slide at Plains All American, PAA Natural Gas https://seekingalpha.com/news/1194682-profits-slide-at-plains-all-american-paa-natural-gas?source=tweet\" data-url=\"https://seekingalpha.com/news/1194682-profits-slide-at-plains-all-american-paa-natural-gas\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194612\" data-ts=\"1375740679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KND\" target=\"_blank\">KND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194612-more-on-kindred-healthcare-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Kindred Healthcare earnings</a></h4><ul>     <li>Kindred Healthcare (NYSE:<a href=\"https://seekingalpha.com/symbol/KND\" title=\"Kindred Healthcare, Inc.\">KND</a>) <a href=\"https://seekingalpha.com/market_currents/post/1194432\" target=\"_blank\">Q2 misses</a> across the board, as total revenue fell slightly from the same period last year due to federal sequestration cuts and bottom line margins were hit by impairment charges.</li>\n<li>RehabCare division reported 7% growth in operating income, driven by better cost controls.</li>\n<li>Home Health and Hospice revenues rose 84% compared to last year.</li>\n<li>Reaffirms FY13 EPS guidance in-line with Street estimates.</li>\n<li>Raises FY13 operating cash flow guidance to a range between $235M to $255M from $230M to $250M, and lowers its estimated routine capital expenditures to a range of $112M to $122M from its prior range of $120M to $130M.</li>\n<li>Shares <font color=\"green\">+5.5%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194612\" data-linked=\"More on Kindred Healthcare earnings\" data-tweet=\"$KND - More on Kindred Healthcare earnings https://seekingalpha.com/news/1194612-more-on-kindred-healthcare-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1194612-more-on-kindred-healthcare-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194512\" data-ts=\"1375739653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DSW\" target=\"_blank\">DSW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194512-dsw-raises-fy13-earnings-guidance-unveils-2-forminus-1-stock-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DSW raises FY13 earnings guidance, unveils 2-for-1 stock split</a></h4><ul>\n<li>DSW (NYSE:<a href=\"https://seekingalpha.com/symbol/DSW\" title=\"DSW Inc.\">DSW</a>) lifts its FY13 earnings guidance and reports same-store sales growth for the second quarter.</li>\n<li>It now expects full year earnings to come in around $3.60 to $3.80 per share, up from the previous range of $3.40 to $3.60 per share, assuming low single digit same store sales growth for the full year.</li>\n<li>Net sales came in at approximately $558M for the period ended August 3, compared to  $512M for the year-ago period, an increase of approximately 9%.</li>\n<li>Same store sales, excluding sales from the company's luxury initiative, rose 4.3%, compared to last year's 4.2% increase.</li>\n<li>The company also unveils plans for a 2-for-1 stock split.</li>\n<li>Shares <font color=\"green\">+2%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1194512\" data-linked=\"DSW raises FY13 earnings guidance, unveils 2-for-1 stock split\" data-tweet=\"$DSW $DBI - DSW raises FY13 earnings guidance, unveils 2-for-1 stock split https://seekingalpha.com/news/1194512-dsw-raises-fy13-earnings-guidance-unveils-2-forminus-1-stock-split?source=tweet\" data-url=\"https://seekingalpha.com/news/1194512-dsw-raises-fy13-earnings-guidance-unveils-2-forminus-1-stock-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194502\" data-ts=\"1375739596\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VCRA\" target=\"_blank\">VCRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194502-vocera-beats-by-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vocera beats by $0.05, beats on revenue</a></h4><ul>     <li>Vocera (NYSE:<a href=\"https://seekingalpha.com/symbol/VCRA\" title=\"Vocera Communications\">VCRA</a>): Q2 EPS of $0.01 <font color=\"green\">beats by $0.05</font>.</li>\n<li>Revenue of $25.3M <font color=\"green\">beats by $1.14M</font>. Shares  <font color=\"red\">-15.5%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194502\" data-linked=\"Vocera beats by $0.05, beats on revenue\" data-tweet=\"$VCRA - Vocera beats by $0.05, beats on revenue https://seekingalpha.com/news/1194502-vocera-beats-by-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1194502-vocera-beats-by-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194412\" data-ts=\"1375738787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LKM\" target=\"_blank\">LKM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194412-nq-mobile-again-soars-to-new-highs-ahead-of-q2-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NQ Mobile again soars to new highs ahead of Q2 report</a></h4><ul>     <li>Following today's gains, NQ (NQ <font color=\"green\">+12.7%</font>) is <font color=\"green\">up 197%</font> YTD and <font color=\"green\">83%</font> since the company's July 15 <a href=\"https://seekingalpha.com/currents/post/1138402\" target=\"_blank\">Q2 pre-announcement</a>.</li>     <li>Earlier today, SA contributor/hedge fund manager <a href=\"https://seekingalpha.com/article/1603612-nq-mobile-pure-play-mobile-game-and-mobile-security-hyper-growth-company-is-still-dirt-cheap\" target=\"_blank\">Treasure Hunter</a> declared NQ \"is still dirt cheap\" in another bullish write-up (previous). He notes the mobile software firm \"is still not followed by a single bulge bracket broker,\" and didn't have a single 3%+ institutional owner as of a month ago.</li>     <li>On Friday, NQ announced it had <a href=\"https://seekingalpha.com/article/1603612-nq-mobile-pure-play-mobile-game-and-mobile-security-hyper-growth-company-is-still-dirt-cheap\" target=\"_blank\">extended</a> its linchpin mobile security software partnership with China Mobile (in place since 2010).</li>     <li>Q2 results (likely to be accompanied by guidance) are due on Aug. 12.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194412\" data-linked=\"NQ Mobile again soars to new highs ahead of Q2 report\" data-tweet=\"$LKM - NQ Mobile again soars to new highs ahead of Q2 report https://seekingalpha.com/news/1194412-nq-mobile-again-soars-to-new-highs-ahead-of-q2-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1194412-nq-mobile-again-soars-to-new-highs-ahead-of-q2-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194372\" data-ts=\"1375738464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TALO\" target=\"_blank\">TALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194372-stone-energy-beats-by-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stone Energy beats by $0.09, beats on revenue</a></h4><ul>     <li>Stone Energy (SGY): Q2 EPS of $0.78 <font color=\"green\">beats by $0.09</font>.</li>\n<li>Revenue of $245.9M (+8.5% Y/Y) <font color=\"green\">beats by $21M</font>.</li>\n<li>Shares <font color=\"green\">+2.8%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194372\" data-linked=\"Stone Energy beats by $0.09, beats on revenue\" data-tweet=\"$TALO - Stone Energy beats by $0.09, beats on revenue https://seekingalpha.com/news/1194372-stone-energy-beats-by-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1194372-stone-energy-beats-by-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194362\" data-ts=\"1375738279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194362-after-hours-top-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/MKTG' title='Responsys'>MKTG</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ININ' title='Interactive Intelligence, Inc.'>ININ</a> <font color='green'>+7%</font>. GTAT <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/DSW' title='DSW Inc.'>DSW</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/MDR' title='McDermott International, Inc.'>MDR</a> <font color='red'>-12%</font>. SWHC <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='red'>-5%</font>. SNTA <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194362\" data-linked=\"After-hours top gainers / Losers\" data-tweet=\"$MKTG $ININ $GTATQ - After-hours top gainers / Losers https://seekingalpha.com/news/1194362-after-hours-top-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1194362-after-hours-top-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194352\" data-ts=\"1375737979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XCO\" target=\"_blank\">XCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194352-more-on-exco-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on EXCO earnings</a></h4><ul>\n<li>EXCO Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/XCO\" title=\"EXCO Resources, Inc.\">XCO</a>) <a href=\"https://seekingalpha.com/market_currents/post/1193872\" target=\"_blank\">Q2 misses</a> on its EPS but beats on revenue.</li>\n<li>Oil, natural gas and NGL production was 38 Bcfe, or 420 Mmcfe per day, compared with 50 Bcfe, or 550 Mmcfe per day in Q212.</li>\n<li>Oil, natural gas and NGL revenues were $150M compared with $118M in the prior year.</li>\n<li>Average sales price per Mcfe increased to $3.93 per Mcfe from $2.36 per Mcfe a year earlier.</li>\n<li>Operating costs per Mcfe were favorably impacted by the contribution of certain conventional properties stemming from its EXCO/HGI partnership in Q1. Shares <font color=\"green\">+2%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1194352\" data-linked=\"More on EXCO earnings\" data-tweet=\"$XCO - More on EXCO earnings https://seekingalpha.com/news/1194352-more-on-exco-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1194352-more-on-exco-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194332\" data-ts=\"1375737808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THO\" target=\"_blank\">THO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194332-thor-industries-announces-record-preliminary-sales-improved-backlog\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thor Industries announces record preliminary sales, improved backlog</a></h4><ul>     <li>Thor Industries (NYSE:<a href=\"https://seekingalpha.com/symbol/THO\" title=\"Thor Industries, Inc.\">THO</a>) announces preliminary FQ4 sales results: Sales rose 15.2% Y/Y to $1.023B vs. $975.9M consensus.</li>     <li>RV backlog on July 31 was $441.5M, up 31.7% Y/Y; towable RV backlog rose 1.7% to $228.4M; motorized RV  backlog  nearly doubled to $213.1M.</li>     <li>Shares <font color=\"green\">+1.9%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194332\" data-linked=\"Thor Industries announces record preliminary sales, improved backlog\" data-tweet=\"$THO - Thor Industries announces record preliminary sales, improved backlog https://seekingalpha.com/news/1194332-thor-industries-announces-record-preliminary-sales-improved-backlog?source=tweet\" data-url=\"https://seekingalpha.com/news/1194332-thor-industries-announces-record-preliminary-sales-improved-backlog\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194222\" data-ts=\"1375736713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDR\" target=\"_blank\">MDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194222-more-on-mcdermott-international-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on McDermott International earnings</a></h4><ul>     <li>McDermott International (NYSE:<a href=\"https://seekingalpha.com/symbol/MDR\" title=\"McDermott International, Inc.\">MDR</a>) <a href=\"https://seekingalpha.com/market_currents/post/1194032\" target=\"_blank\">Q2 misses hard</a> as revenues fell 28% Y/Y on heavy charges.</li>     <li>Project-related charges resulted in operating losses in its Asia Pacific and Middle East segments, due to delays on a deepwater pipelay project in Malaysia and a $38M million charge to one project in Saudi Arabia.</li>     <li>The company also commenced restructuring of its Atlantic operations, including personnel reductions in Houston and New Orleans as well as a relocation of its Morgan City fabrication and marine activities to Altamira, Mexico.</li>     <li>Restructuring costs are expected to range between $45M to $60M.</li>     <li>Backlog was approximately $5.1B at the end of June, compared to $5.3B in March. Approximately $375.1M of the backlog was derived from three projects that are currently in a loss position, relating mostly to the project in the Asia Pacific segment and a five-year charter in  Brazil.</li>     <li>The company announces that its Chief Operating Officer, John T. McCormack, will be retiring in Q4.</li>     <li>Shares <font color=\"red\">-11.8%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194222\" data-linked=\"More on McDermott International earnings\" data-tweet=\"$MDR - More on McDermott International earnings https://seekingalpha.com/news/1194222-more-on-mcdermott-international-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/1194222-more-on-mcdermott-international-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194182\" data-ts=\"1375736520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MKTG\" target=\"_blank\">MKTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194182-responsys-revenue-guidance-strong-shares-jump-to-new-52-week-highs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Responsys revenue guidance strong, shares jump to new 52-week highs</a></h4><ul>     <li>Responsys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MKTG\" title=\"Responsys\">MKTG</a>) expects Q3 revenue of $47M-$48.5M and EPS of $0.02 vs. a consensus of $46.8M and $0.04</li>     <li>2013 guidance is for revenue of $195M-$198M and EPS of $0.15 vs. a consensus of $192.1M and $0.18.</li>     <li>The light EPS guidance is attributed to heavy sales/marketing spend.</li>     <li>Q2 subscription revenue +25% Y/Y to $34.3M, services revenue +25% to $15.2M.</li>     <li>Opex +42% Y/Y to $29.7M, outpacing rev. growth of 25%.</li>     <li>\n<a href=\"https://seekingalpha.com/symbol/MKTG\" title=\"Responsys\">MKTG</a> <font color=\"green\">+10%</font> AH to levels last seen in 2011. Cloud marketing automation software rival Marketo (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MKTO\" title=\"Marketo\">MKTO</a>), which <a href=\"https://seekingalpha.com/currents/post/1180242\" target=\"_blank\">took off last week</a> following its Q2 revenue beat, could rally in sympathy.</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1193602\" target=\"_blank\">Q2 results</a>, PR</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194182\" data-linked=\"Responsys revenue guidance strong, shares jump to new 52-week highs\" data-tweet=\"$MKTG $MKTG $MKTO - Responsys revenue guidance strong, shares jump to new 52-week highs https://seekingalpha.com/news/1194182-responsys-revenue-guidance-strong-shares-jump-to-new-52-week-highs?source=tweet\" data-url=\"https://seekingalpha.com/news/1194182-responsys-revenue-guidance-strong-shares-jump-to-new-52-week-highs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194072\" data-ts=\"1375735959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPO\" target=\"_blank\">MPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194072-midstates-petroleum-misses-by-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midstates Petroleum misses by $0.10, beats on revenue</a></h4><ul>     <li>Midstates Petroleum (NYSE:<a href=\"https://seekingalpha.com/symbol/MPO\" title=\"Midstates Petroleum\">MPO</a>): Q2 EPS of -$0.06 <font color=\"red\">misses by $0.10</font>.</li>\n<li>Revenue of $126M <font color=\"green\">beats by $15.42M</font>. Shares  <font color=\"red\">-1.6%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1194072\" data-linked=\"Midstates Petroleum misses by $0.10, beats on revenue\" data-tweet=\"$MPO $AMPY - Midstates Petroleum misses by $0.10, beats on revenue https://seekingalpha.com/news/1194072-midstates-petroleum-misses-by-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1194072-midstates-petroleum-misses-by-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1194032\" data-ts=\"1375735771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDR\" target=\"_blank\">MDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1194032-mcdermott-misses-by-0_66-revenue-misses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McDermott misses by $0.66, revenue misses</a></h4><ul>\n<li>McDermott International (NYSE:<a href=\"https://seekingalpha.com/symbol/MDR\" title=\"McDermott International, Inc.\">MDR</a>): Q2 EPS loss of $0.63, <font color=\"red\">misses by $0.66 </font>(may not be comparable).</li>\n<li>Revenue of $647.3M (-28% Y/Y) <font color=\"red\">misses by $100M</font>. (PR)</li>\n<li>Shares <font color=\"red\">-11.7%</font> AH.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1194032\" data-linked=\"McDermott misses by $0.66, revenue misses\" data-tweet=\"$MDR - McDermott misses by $0.66, revenue misses https://seekingalpha.com/news/1194032-mcdermott-misses-by-0_66-revenue-misses?source=tweet\" data-url=\"https://seekingalpha.com/news/1194032-mcdermott-misses-by-0_66-revenue-misses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193952\" data-ts=\"1375735238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRW\" target=\"_blank\">TRW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193952-trw-automotive-announces-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TRW Automotive announces secondary offering</a></h4><ul>     <li>TRW Automotive (NYSE:<a href=\"https://seekingalpha.com/symbol/TRW\" title=\"TRW Automotive Holdings Corp.\">TRW</a>) says members of company management and an affiliate of the Blackstone Group will offer a total of 10.9M shares in an underwritten public offering. (PR)</li>     <li>Shares <font color=\"red\">-1.7%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193952\" data-linked=\"TRW Automotive announces secondary offering\" data-tweet=\"$TRW - TRW Automotive announces secondary offering https://seekingalpha.com/news/1193952-trw-automotive-announces-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1193952-trw-automotive-announces-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193812\" data-ts=\"1375734238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNY\" target=\"_blank\">CLNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193812-northstar-realty-finance-to-offer-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NorthStar Realty Finance to offer shares</a></h4><ul>     <li>NorthStar Realty Finance (NRF) slips <font color=\"red\">3%</font> AH after the company announces plans for a 35M share public offering. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193812\" data-linked=\"NorthStar Realty Finance to offer shares\" data-tweet=\"$CLNY - NorthStar Realty Finance to offer shares https://seekingalpha.com/news/1193812-northstar-realty-finance-to-offer-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/1193812-northstar-realty-finance-to-offer-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193782\" data-ts=\"1375734015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTATQ\" target=\"_blank\">GTATQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193782-gt-advanced-eps-beats-by-0_06-revenue-misses-shares-jump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GT Advanced EPS beats by $0.06, revenue misses, shares jump</a></h4><ul>     <li>GT Advanced Technologies (GTAT): Q2 EPS of $0.15 <font color=\"green\">beats by $0.06</font>.</li> <li>Revenue of $168.3M (+1% Y/Y) <font color=\"red\">misses by $0.7M</font>.</li> <li>Reiterates guidance for 2013 revenue of $500M-$600M and EPS of $0.25-$0.45. Consensus is at $532.2M and $0.29.</li> <li>Shares <font color=\"green\">+8.1%</font> AH. CC at 8AM ET tomorrow (<a href=\"http://investor.gtat.com/eventdetail.cfm?eventid=132454\" target=\"_blank\">webcast</a>). (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193782\" data-linked=\"GT Advanced EPS beats by $0.06, revenue misses, shares jump\" data-tweet=\"$GTATQ - GT Advanced EPS beats by $0.06, revenue misses, shares jump https://seekingalpha.com/news/1193782-gt-advanced-eps-beats-by-0_06-revenue-misses-shares-jump?source=tweet\" data-url=\"https://seekingalpha.com/news/1193782-gt-advanced-eps-beats-by-0_06-revenue-misses-shares-jump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193742\" data-ts=\"1375733847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARTC\" target=\"_blank\">ARTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193742-arthrocare-eps-of-0_27-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArthroCare EPS of -$0.27, misses on revenue</a></h4><ul>     <li>ArthroCare (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARTC\" title=\"ArthroCare Corporation\">ARTC</a>): Q2 EPS of -$0.27.</li>\n<li>Revenue of $92.1M <font color=\"red\">misses by $1.57M</font>. Shares  <font color=\"green\">+6.1%</font> AH. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193742\" data-linked=\"ArthroCare EPS of -$0.27, misses on revenue\" data-tweet=\"$ARTC - ArthroCare EPS of -$0.27, misses on revenue https://seekingalpha.com/news/1193742-arthrocare-eps-of-0_27-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/1193742-arthrocare-eps-of-0_27-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193722\" data-ts=\"1375733696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193722-american-eagle-revises-q2-outlook-shares-plunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Eagle revises Q2 outlook, shares plunge</a></h4><ul>     <li>American Eagle (NYSE:<a href=\"https://seekingalpha.com/symbol/AEO\" title=\"American Eagle Outfitters, Inc.\">AEO</a>) says Q2 EPS will likely come in around $0.10/ share versus previous guidance of $0.19-0.21/ share.</li>     <li>Comps growth is now expected to come in at -7%. (PR)</li>     <li>Shares <font color=\"red\">-12.37%</font> AH.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193722\" data-linked=\"American Eagle revises Q2 outlook, shares plunge\" data-tweet=\"$AEO - American Eagle revises Q2 outlook, shares plunge https://seekingalpha.com/news/1193722-american-eagle-revises-q2-outlook-shares-plunge?source=tweet\" data-url=\"https://seekingalpha.com/news/1193722-american-eagle-revises-q2-outlook-shares-plunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193692\" data-ts=\"1375733671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JMBA\" target=\"_blank\">JMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193692-more-on-jambas-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Jamba&#39;s Q2</a></h4><ul>     <li>Jamba's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JMBA\" title=\"Jamba, Inc.\">JMBA</a>) comparable store sales up 2.2% for the quarter.</li>     <li>General and administrative expenses down 5.4% Y/Y to help boost operating margin by 230 bps compared to a year ao.</li>     <li>The company sees comparable store sales growth of 4% to 6% for FY13 and store-level margin of 20%.</li>     <li>JMBA +12% AH on apparent enthusiasm over the firm's outlook.</li>     <li>PR</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193692\" data-linked=\"More on Jamba&#39;s Q2\" data-tweet=\"$JMBA - More on Jamba&#39;s Q2 https://seekingalpha.com/news/1193692-more-on-jambas-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/1193692-more-on-jambas-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193522\" data-ts=\"1375732687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPX\" target=\"_blank\">WPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193522-wpx-plans-to-develop-san-juan-oil-discovery\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WPX plans to develop San Juan oil discovery</a></h4><ul>     <li>WPX Energy (<a href=\"https://seekingalpha.com/symbol/WPX\" title=\"WPX Energy, Inc.\">WPX</a> <font color=\"green\">+2.6%</font>) <a href=\"http://www.ogj.com/articles/2013/08/wpx-to-develop-san-juan-gallup-oil-discovery.html\" target=\"_blank\">plans to drill</a> 8-10 development wells in New Mexico in 2013 near a San Juan basin oil discovery at which the first four  wells flowed at commercial rates.</li>     <li>The new field is expected to produce 3,400 boe/day by year-end; WPX says it has already spudded three of the development  wells.</li>     <li>WPX also continues plans to drill four horizontal Niobrara wells in the Piceance basin in 2013 as a first step in the delineation of its Niobrara discovery.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193522\" data-linked=\"WPX plans to develop San Juan oil discovery\" data-tweet=\"$WPX - WPX plans to develop San Juan oil discovery https://seekingalpha.com/news/1193522-wpx-plans-to-develop-san-juan-oil-discovery?source=tweet\" data-url=\"https://seekingalpha.com/news/1193522-wpx-plans-to-develop-san-juan-oil-discovery\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193472\" data-ts=\"1375731740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTR\" target=\"_blank\">NTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193472-potash-moves-up-on-sector-consolidation-chatter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Potash moves up on sector consolidation chatter</a></h4><ul>     <li>Potash (POT <font color=\"green\">+2%</font>) shares enjoy solid gains following remarks by Russian producer Uralkali\u2019s CEO that <a href=\"http://www.reuters.com/article/2013/08/05/us-russia-uralkali-potash-idUSBRE97404I20130805\" target=\"_blank\">consolidation would be a logical step</a> for the sector when potash prices fall to a level of marginal producers, though it's too early to predict possible deals as the valuation of individual companies is now unclear.</li>     <li>Mosaic (<a href=\"https://seekingalpha.com/symbol/MOS\" title=\"The Mosaic Company\">MOS</a> <font color=\"green\">+1.2%</font>) also is higher amid <a href=\"http://blogs.barrons.com/stockstowatchtoday/2013/08/05/potash-roundup-uralkali-sees-consolidation-agrium-falls-on-downgrade\" target=\"_blank\">rumors</a> it might be a takeover target for BHP Billiton (<a href=\"https://seekingalpha.com/symbol/BHP\" title=\"BHP Billiton Limited\">BHP</a> <font color=\"green\">+0.3%</font>).</li>     <li>Agrium (AGU <font color=\"red\">-0.5%</font>) is left out of the gainers after shares are <a href=\"https://seekingalpha.com/currents/post/1192692\" target=\"_blank\">downgraded</a> at Stifel Nicolaus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193472\" data-linked=\"Potash moves up on sector consolidation chatter\" data-tweet=\"$NTR $NTR $MOS - Potash moves up on sector consolidation chatter https://seekingalpha.com/news/1193472-potash-moves-up-on-sector-consolidation-chatter?source=tweet\" data-url=\"https://seekingalpha.com/news/1193472-potash-moves-up-on-sector-consolidation-chatter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193462\" data-ts=\"1375731591\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HYGS\" target=\"_blank\">HYGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193462-hydrogenics-slides-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hydrogenics slides again</a></h4><ul>     <li>Shares of Hydrogenics (<a href='https://seekingalpha.com/symbol/HYGS' title='Hydrogenics Corporation'>HYGS</a> <font color='red'>-6.5%</font>) remain stuck in a <a href=\"https://seekingalpha.com/currents/post/1186022\" target=\"_blank\">post-earnings rut</a>, falling considerably again today, bringing losses since last Wednesday to <font color='red'>~24%</font>.</li>     <li>Not helping matters is a <a href=\"http://www.streetinsider.com/Downgrades/Ascendiant+Capital+Downgrades+Hydrogenics+%28HYGS%29+to+Neutral/8565012.html\" target=\"_blank\">downgrade</a> from Ascendiant Capital to Neutral from Buy.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193462\" data-linked=\"Hydrogenics slides again\" data-tweet=\"$HYGS - Hydrogenics slides again https://seekingalpha.com/news/1193462-hydrogenics-slides-again?source=tweet\" data-url=\"https://seekingalpha.com/news/1193462-hydrogenics-slides-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193442\" data-ts=\"1375731033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REV\" target=\"_blank\">REV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193442-revlon-deal-lauded\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revlon deal lauded</a></h4><ul> <li>Revlon's (<a href=\"https://seekingalpha.com/symbol/REV\" title=\"Revlon, Inc.\">REV</a> <font color=\"green\">+6.1%</font>) deal to buy Colomer <a href=\"http://www.bloomberg.com/news/2013-08-05/revlon-to-acquire-colomer-group-for-660-million.html\" target=\"_blank\">looks like a winner</a> to industry watchers.</li> <li>The deal is expected to immediately impact earnings with Colomer's focus in Europe, Africa, and the Middle East complementing Revlon's U.S.-heavy global presence.</li> <li>It also gives Revlon a rapid-fire entry into the professional salon channel.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193442\" data-linked=\"Revlon deal lauded\" data-tweet=\"$REV - Revlon deal lauded https://seekingalpha.com/news/1193442-revlon-deal-lauded?source=tweet\" data-url=\"https://seekingalpha.com/news/1193442-revlon-deal-lauded\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193422\" data-ts=\"1375730689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSIR\" target=\"_blank\">OSIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193422-osiris-therapeutics-slides-after-its-q2-eps-fall-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Osiris Therapeutics slides after its  Q2 EPS fall short</a></h4><ul>\n<li>Osiris Therapeutics (<a href=\"https://seekingalpha.com/symbol/OSIR\" title=\"Osiris Therapeutics, Inc.\">OSIR</a> <font color=\"red\">-5.1%</font>) slips after it <a href=\"https://seekingalpha.com/market_currents/post/1192202\" target=\"_blank\">Q2 missed estimates</a> earlier this morning.</li>\n<li>Product revenue beat, up 231% from Q212, but its net loss was $0.11 per share, wider than estimates for a $0.09 loss.</li>\n<li>R&amp;D expenses declined, but higher SG&amp;A costs due to increased commercial activity cut into it bottom line.</li>\n<li>Gross margin improved to 72% compared to 66% in the prior year period.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193422\" data-linked=\"Osiris Therapeutics slides after its  Q2 EPS fall short\" data-tweet=\"$OSIR - Osiris Therapeutics slides after its Q2 EPS fall short https://seekingalpha.com/news/1193422-osiris-therapeutics-slides-after-its-q2-eps-fall-short?source=tweet\" data-url=\"https://seekingalpha.com/news/1193422-osiris-therapeutics-slides-after-its-q2-eps-fall-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193412\" data-ts=\"1375730345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMCR\" target=\"_blank\">GMCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193412-green-mountain-perks-up-after-barrons-induced-hangover\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Mountain perks up after Barron&#39;s-induced hangover</a></h4><ul>\n<li>After spending the morning in the red following a <a href=\"https://seekingalpha.com/currents/post/1192272\" target=\"_blank\">downbeat <em>Barron's</em> mention</a> over the weekend, shares of Green Mountain Coffee (<a href=\"https://seekingalpha.com/symbol/GMCR\" title=\"Keurig Green Mountain Inc\">GMCR</a> <font color=\"green\">+3.4%</font>) move higher in afternoon trading.</li>\n<li>\"We expect the company to announce at least one new partnership (in a new  channel) and extend its existing deal with The J.M. Smucker Company in the upcoming weeks and months,\" KeyBanc's Akshay Jagdale says, <a href=\"http://www.streetinsider.com/Analyst+Comments/Green+Mountain+%28GMCR%29+Expected+to+Announce+New+Partnership/8566284.html\" target=\"_blank\">reiterating a Buy</a> rating (PT, $90).</li>\n<li>More from Jagdale: \"We believe sales growth will eventually accelerate on the back of new  channel penetration, brewer innovation, international expansion, new  beverage opportunities, and stabilization of share losses.\" That pretty much covers it \u2014 what's not to like?</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193412\" data-linked=\"Green Mountain perks up after Barron&#39;s-induced hangover\" data-tweet=\"$GMCR - Green Mountain perks up after Barron&#39;s-induced hangover https://seekingalpha.com/news/1193412-green-mountain-perks-up-after-barrons-induced-hangover?source=tweet\" data-url=\"https://seekingalpha.com/news/1193412-green-mountain-perks-up-after-barrons-induced-hangover\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193402\" data-ts=\"1375730142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECK\" target=\"_blank\">TECK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193402-teck-resources-a-top-pick-at-fbr-to-buck-production-costs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teck Resources a top pick at FBR to buck production costs</a></h4><ul>     <li>FBR Capital adds Teck Resources (TCK <font color=\"green\">+0.7%</font>) to its <a href=\"http://online.barrons.com/article/SB50001424052748703759004578650011233621112.html\" target=\"_blank\">Top Picks</a> list as the company has deferred some  less attractive projects, reduced cash flow breakeven as capex is reduced in the short term, maintains a solid balance sheet with a debt/total cap ratio of 36%; and should benefit from an eventual met coal price recovery.</li>     <li>The firm notes TCK has indicated it will not jeopardize its balance sheet strength or investment grade rating, and it will focus on strong cash flow generating assets.</li>     <li>Consol Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/CNX\" title=\"CNX Resources Corporation\">CNX</a>) is FBR's favorite steam-coal play; the firm <a href=\"https://seekingalpha.com/currents/post/1192372\" target=\"_blank\">downgrades</a> Alpha Natural Resources (ANR <font color=\"green\">+3%</font>) to Market Perform.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193402\" data-linked=\"Teck Resources a top pick at FBR to buck production costs\" data-tweet=\"$TECK $TECK $CNX - Teck Resources a top pick at FBR to buck production costs https://seekingalpha.com/news/1193402-teck-resources-a-top-pick-at-fbr-to-buck-production-costs?source=tweet\" data-url=\"https://seekingalpha.com/news/1193402-teck-resources-a-top-pick-at-fbr-to-buck-production-costs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193362\" data-ts=\"1375728965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GALT\" target=\"_blank\">GALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193362-galectin-therapeutics-slides-despite-promising-new-data-on-its-lung-fibrosis-therapy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galectin Therapeutics slides despite promising new data on its lung fibrosis therapy</a></h4><ul>\n<li>Galectin Therapeutics (<a href=\"https://seekingalpha.com/symbol/GALT\" title=\"Galectin Therapeutics, Inc.\">GALT</a> <font color=\"red\">-4.9%</font>) slips again today, despite saying new preclinical data on the efficacy of GR-MD-02, its anti-galectin therapy for lung fibrosis, was effective in reducing the disease.</li>\n<li>The trials used a model that simulates the human disease idiopathic pulmonary fibrosis.</li>\n<li>In it, treatment with GR-MD-02 showed a robust effect in reducing lung fibrosis, with somewhat lesser effect of GM-CT-01.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193362\" data-linked=\"Galectin Therapeutics slides despite promising new data on its lung fibrosis therapy\" data-tweet=\"$GALT - Galectin Therapeutics slides despite promising new data on its lung fibrosis therapy https://seekingalpha.com/news/1193362-galectin-therapeutics-slides-despite-promising-new-data-on-its-lung-fibrosis-therapy?source=tweet\" data-url=\"https://seekingalpha.com/news/1193362-galectin-therapeutics-slides-despite-promising-new-data-on-its-lung-fibrosis-therapy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193332\" data-ts=\"1375727966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXM\" target=\"_blank\">CXM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193332-cardium-therapeutics-files-a-new-510k-submission-with-the-fda-for-excellagen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cardium Therapeutics files a new 510K submission with the FDA for Excellagen</a></h4><ul>\n<li>Cardium Therapeutics (<a href=\"https://seekingalpha.com/symbol/CXM\" title=\"Cardium Therapeutics, Inc\">CXM</a> <font color=\"green\">+3.3%</font>) gains after it files a new 510(k) submission for its current FDA-cleared Excellagen advanced wound care product</li>\n<li>The new submission reflects updated information on specific structural and functional properties of the drug from ongoing supplemental R&amp;D.</li>\n<li>The findings including electron microscopy data that should allow for more specific labeling to include the unique structural and biological properties of Excellagen and its to potential to enhance platelet activation when used in concert with Platelet Rich Plasma therapy.</li>\n<li>Additionally, the company plans to modify the drug's packaging to include individually pouched applicator syringes and a large volume syringe applicator to allow for easier use in larger-sized wounds.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193332\" data-linked=\"Cardium Therapeutics files a new 510K submission with the FDA for Excellagen\" data-tweet=\"$CXM - Cardium Therapeutics files a new 510K submission with the FDA for Excellagen https://seekingalpha.com/news/1193332-cardium-therapeutics-files-a-new-510k-submission-with-the-fda-for-excellagen?source=tweet\" data-url=\"https://seekingalpha.com/news/1193332-cardium-therapeutics-files-a-new-510k-submission-with-the-fda-for-excellagen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193312\" data-ts=\"1375727683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBOE\" target=\"_blank\">CBOE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193312-cboe-falls-on-goldman-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBOE falls on Goldman downgrade</a></h4><ul>     <li>Goldman says its <a href=\"http://finance.yahoo.com/news/analysts-actions-bcom-cboe-teva-121600601.html\" target=\"_blank\">downgrade</a> of CBOE (<a href='https://seekingalpha.com/symbol/CBOE' title='CBOE Holdings'>CBOE</a> <font color='red'>-4.4%</font>), which comes in the wake of the options exchange's <a href=\"https://seekingalpha.com/currents/post/1189662\" target=\"_blank\">FQ1 report</a>, is a valuation call.</li>     <li>Shares currently trade at 24x 2013E EPS, and remain <strong><font color='green'>up 67%</font></strong> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193312\" data-linked=\"CBOE falls on Goldman downgrade\" data-tweet=\"$CBOE - CBOE falls on Goldman downgrade https://seekingalpha.com/news/1193312-cboe-falls-on-goldman-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1193312-cboe-falls-on-goldman-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193292\" data-ts=\"1375726929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193292-tysons-meaty-quarter-helps-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyson&#39;s meaty quarter helps peers</a></h4><ul> <li>Shares of Tyson Foods (<a href=\"https://seekingalpha.com/symbol/TSN\" title=\"Tyson Foods Inc.\">TSN</a> <font color=\"green\">+4.3%</font>) are higher after the company surprised analysts with a <a href=\"https://seekingalpha.com/currents/post/1192102\" target=\"_blank\">brisk quarter</a> led by steady demand for chicken, pork, and beef products. The trend of restaurants and consumers moving toward a higher mix of lower-margin chicken products seems to have abated, which is also welcome relief for Tyson.</li> <li>Peers are out-performing market averages for the days on the good sector news. <a href=\"https://seekingalpha.com/symbol/SFD\" title=\"Smithfield Foods Inc.\">SFD</a> <font color=\"green\">+0.1%</font>, <a href=\"https://seekingalpha.com/symbol/HRL\" title=\"Hormel Foods Corporation\">HRL</a> <font color=\"green\">+0.2%</font>, <a href=\"https://seekingalpha.com/symbol/PPC\" title=\"Pilgrim's Pride Corporation\">PPC</a> <font color=\"green\">+0.4%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1193292\" data-linked=\"Tyson&#39;s meaty quarter helps peers\" data-tweet=\"$TSN $TSN $SFD - Tyson&#39;s meaty quarter helps peers https://seekingalpha.com/news/1193292-tysons-meaty-quarter-helps-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/1193292-tysons-meaty-quarter-helps-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193262\" data-ts=\"1375726476\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193262-needham-sees-weakness-in-isis-as-buying-opportunity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham sees weakness in Isis as buying opportunity</a></h4><ul><li>Needham's Chad Messer doesn't want investors to fret over Isis Pharmaceutical's (ISIS <font color='red'>-2.6%</font>) <a href=\"https://seekingalpha.com/currents/post/1192222\" target=\"_blank\">decision to discontinue</a> development of ISIS-CRP treatment for rheumatoid arthritis.</li><li>In fact, Messer thinks today's weakness may be a buying opportunity as he never thought RA was \"<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/08/3812622/needham-says-buy-the-dip-in-isis-pharma-didnt-see-favora\" target=\"_blank\">a serious consideration</a>\" for ISIS-CRP in the first place.</li></ul><div class=\"tiny-share-widget\" data-id=\"1193262\" data-linked=\"Needham sees weakness in Isis as buying opportunity\" data-tweet=\"$IONS - Needham sees weakness in Isis as buying opportunity https://seekingalpha.com/news/1193262-needham-sees-weakness-in-isis-as-buying-opportunity?source=tweet\" data-url=\"https://seekingalpha.com/news/1193262-needham-sees-weakness-in-isis-as-buying-opportunity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193252\" data-ts=\"1375725718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROYL\" target=\"_blank\">ROYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193252-royale-energy-shoots-higher-after-issuing-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Royale Energy shoots higher after issuing Q2 results</a></h4><ul>     <li>Royale Energy (<a href='https://seekingalpha.com/symbol/ROYL' title='Royale Energy, Inc.'>OTC:ROYL</a> <font color='green'>+8.4%</font>) reports Q2 EPS of $0.14 vs. $0.01 single analyst estimate, and revenues up 75.5% Y/Y to $1.54M vs $2.4M single estimate. (<a href=\"http://www.sec.gov/Archives/edgar/data/864839/000118518513001567/royaleenergy10q063013.htm\" target=\"_blank\">10-Q</a>)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193252\" data-linked=\"Royale Energy shoots higher after issuing Q2 results\" data-tweet=\"$ROYL - Royale Energy shoots higher after issuing Q2 results https://seekingalpha.com/news/1193252-royale-energy-shoots-higher-after-issuing-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1193252-royale-energy-shoots-higher-after-issuing-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193232\" data-ts=\"1375725088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193232-nikkei-sandisk-toshiba-to-build-400b-4_1b-fab\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nikkei: SanDisk, Toshiba to build ¥400B ($4.1B) fab</a></h4><ul>\n<li>\n<a href=\"http://e.nikkei.com/e/app/fr/gateway/rss_news.aspx?URL=%2Fe%2Fac%2Ftnks%2FNni20130805D0508F01.htm&amp;utm_source=dlvr.it&amp;utm_medium=twitter\" target=\"_blank\"><em>Nikkei</em>'s report</a> about a new NAND flash fab to be built by SanDisk (SNDK <font color=\"red\">-1.1%</font>) and Toshiba (<a href=\"https://seekingalpha.com/symbol/TOSBF\" title=\"Toshiba Corp.\">OTCPK:TOSBF</a>) comes amidst <a href=\"https://seekingalpha.com/currents/post/1175062\" target=\"_blank\">growing analyst fears</a> new capacity additions will lead the current NAND up cycle to peak, in spite of strong smartphone/tablet/SSD-related demand.</li>\n<li>\n<a href=\"http://press.dramexchange.com/en/node/5830?utm_source=twitterfeed&amp;utm_medium=twitter\" target=\"_blank\">DRAMeXchange recently estimated</a> NAND contract prices fell 6%-9% in 2H July. The firm says the market has been \"more sluggish than expected\" in Q3.</li>\n<li>SanDisk is lower, but rival Micron (<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a> <font color=\"green\">+3.7%</font>) is rallying, possibly thanks to the SIA's June/Q2 <a href=\"http://blogs.barrons.com/techtraderdaily/2013/08/05/chips-street-sees-half-empty-half-full-glass-in-sia-data\" target=\"_blank\">sales data</a>. The trade association estimates DRAM sales rose 22% Q/Q in Q2. Flash memory sales are believed to have risen 8.6%.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193232\" data-linked=\"Nikkei: SanDisk, Toshiba to build ¥400B ($4.1B) fab\" data-tweet=\"$WDC $WDC $TOSBF - Nikkei: SanDisk, Toshiba to build ¥400B ($4.1B) fab https://seekingalpha.com/news/1193232-nikkei-sandisk-toshiba-to-build-400b-4_1b-fab?source=tweet\" data-url=\"https://seekingalpha.com/news/1193232-nikkei-sandisk-toshiba-to-build-400b-4_1b-fab\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193212\" data-ts=\"1375724862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPRX\" target=\"_blank\">RPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193212-repros-dips-on-concern-over-the-validity-of-its-androxal-patent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Repros dips on concern over the validity of its Androxal patent</a></h4><ul>\n<li>Repros Therapeutics (<a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> <font color=\"red\">-2.8%</font>) dips on <a href=\"http://www.thestreet.com/story/11999214/1/repros-worried-about-validity-of-its-androxal-patent.html\" target=\"_blank\">a negative article</a> in TheStreet.com saying the company is worried about the validity of its Androxal patent.</li>\n<li>Despite reassurances by <a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a>, recent action it's taken to obtain a declaratory judgment affirming its intellectual property rights in a Texas court suggests the company is actually much more worried than it lets on about the risk of it being invalidated.</li>\n<li>A New York urologist has accused <a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> CEO Joe Podolski of stealing the idea for Androxal from him after a face-to-face meeting in New York City.</li>\n<li>Podolski denies Fisch's theft charge, but Repros began developing the drug after the meeting between the two men.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193212\" data-linked=\"Repros dips on concern over the validity of its Androxal patent\" data-tweet=\"$RPRX - Repros dips on concern over the validity of its Androxal patent https://seekingalpha.com/news/1193212-repros-dips-on-concern-over-the-validity-of-its-androxal-patent?source=tweet\" data-url=\"https://seekingalpha.com/news/1193212-repros-dips-on-concern-over-the-validity-of-its-androxal-patent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193202\" data-ts=\"1375724764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TKR\" target=\"_blank\">TKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193202-timken-rises-as-relational-ups-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Timken rises as Relational ups stake</a></h4><ul>\n<li>Shares of Timken (<a href=\"https://seekingalpha.com/symbol/TKR\" title=\"Timken Co.\">TKR</a> <font color=\"green\">+1.2%</font>) move higher midday after Relational Investors ups its stake in the company to 7.9% from 6.9% (<a href=\"http://archive.fast-edgar.com/20130805/AabkKXnf-9C-6s-c-fx2j-2-hqL6-yfO/\" target=\"_blank\">13-D/A</a>)</li>\n<li>The SEC filing indicates that Relational has \"met with members of [TKR's] special committee and representatives of Goldman Sachs.\" The activist fund is apparently confident that the company will decide to split its steel and bearings businesses.</li>\n<li>See our <a href=\"https://seekingalpha.com/currents/search?query=timken+relational\" target=\"_blank\">previous coverage</a> of the Timken/ Relational/ CalSTRS saga.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193202\" data-linked=\"Timken rises as Relational ups stake\" data-tweet=\"$TKR - Timken rises as Relational ups stake https://seekingalpha.com/news/1193202-timken-rises-as-relational-ups-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/1193202-timken-rises-as-relational-ups-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193172\" data-ts=\"1375723737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTP\" target=\"_blank\">NTP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193172-nam-tai-plunges-after-providing-q2-results-bleak-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nam Tai plunges after providing Q2 results, bleak outlook</a></h4><ul>\n<li>Excluding $30.7M in revenue from Nam Tai's (NTE <font color=\"red\">-14.5%</font>) discontinued tablet LCD manufacturing ops, Q2 revenue rose 64% Y/Y to $167.9M.</li>\n<li>Gross margin was 9.6%, up from 4.1% in Q1 but down from 15% a year ago.</li>\n<li>Nam Tai halted manufacturing at its Wuxi, China tablet LCD facility (<a href=\"https://seekingalpha.com/currents/post/977171\" target=\"_blank\">previous</a>) at the end of May \"due to a lack of new customer orders and after it was unsuccessful in finding a joint venture partner.\" The company is looking to sell the facility.</li>\n<li>Nam Tai's Shenzhen facility has received a smartphone LCD order in Q3 from \"an existing customer\" (Apple?), but the customer is still expected to move production to a lower-cost supplier in time.</li>\n<li>Customer orders are expected to remain \"volatile,\" with continued price pressure, and the amount of <a href=\"http://en.wikipedia.org/wiki/Electronics_manufacturing_services\" target=\"_blank\">EMS services</a> provided by Nam Tai is expected to be \"further reduced significantly.\"</li>\n<li>All \"commercially viable alternatives\" are being explored to continue LCD manufacturing. Also, Nam Tai is looking to convert another Shenzhen facility into \"a high-end commercial complex.\"</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1191932\" target=\"_blank\">Q2 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193172\" data-linked=\"Nam Tai plunges after providing Q2 results, bleak outlook\" data-tweet=\"$NTP - Nam Tai plunges after providing Q2 results, bleak outlook https://seekingalpha.com/news/1193172-nam-tai-plunges-after-providing-q2-results-bleak-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/1193172-nam-tai-plunges-after-providing-q2-results-bleak-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193152\" data-ts=\"1375722114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193152-virnetx-joins-list-of-ip-firms-selling-off-following-white-house-veto\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX joins list of IP firms selling off following White House veto</a></h4><ul>\n<li>VirnetX (<a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a> <font color=\"red\">-4.3%</font>) has joined <a href=\"https://seekingalpha.com/currents/post/1192682\" target=\"_blank\">InterDigital and Acacia</a> in trading lower after the Obama administration <a href=\"http://news.cnet.com/8301-13579_3-57596877-37/obama-vetoes-apple-sales-ban-in-u.s/\" target=\"_blank\">vetoed</a> an ITC sales ban on older iPhones/iPads ruled to be infringing standards-essential Samsung IP.</li>\n<li>The ruling has <a href=\"http://online.wsj.com/article/SB10001424127887323420604578648272862276836.html\" target=\"_blank\">raised concerns</a> about the ITC's effectiveness as a vehicle to pursue infringement complaints, particularly ones involving standards-essential patents.</li>\n<li>VirnetX <a href=\"https://seekingalpha.com/currents/post/855011\" target=\"_blank\">announced in February</a> it would withdraw its ITC complaint against Apple, after obtaining a favorable Texas <a href=\"https://seekingalpha.com/currents/post/646121\" target=\"_blank\">jury verdict</a>.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/post/1066471\" target=\"_blank\">In June</a>, the White House announced executive actions and legislative proposals aimed at perceived patent trolls.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193152\" data-linked=\"VirnetX joins list of IP firms selling off following White House veto\" data-tweet=\"$VHC - VirnetX joins list of IP firms selling off following White House veto https://seekingalpha.com/news/1193152-virnetx-joins-list-of-ip-firms-selling-off-following-white-house-veto?source=tweet\" data-url=\"https://seekingalpha.com/news/1193152-virnetx-joins-list-of-ip-firms-selling-off-following-white-house-veto\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193132\" data-ts=\"1375722044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGO\" target=\"_blank\">PRGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193132-luck-of-the-irish-jazz-alkermes-rally-on-deal-speculation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Luck of the Irish: Jazz, Alkermes rally on deal speculation</a></h4><ul>\n<li>Perrigo's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PRGO\" title=\"Perrigo Company\">PRGO</a>) <a href=\"https://seekingalpha.com/currents/search?query=perrigo+elan\" target=\"_blank\">recent deal for Elan</a> has investors all jazzed up about Irish-domiciled healthcare companies.</li>\n<li>The allure of a 12.5% corporate tax rate could mean more M&amp;A activity in the not-so-distant future for \"anything with an Irish corporate tax structure,\" one analyst tells Bloomberg.</li>\n<li>Some of the names being tossed about: Jazz Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/JAZZ\" title=\"Jazz Pharmaceuticals, Inc.\">JAZZ</a> <font color=\"green\">+3.2%</font>) and Alkermes (<a href=\"https://seekingalpha.com/symbol/ALKS\" title=\"Alkermes plc\">ALKS</a> <font color=\"green\">+3.8%</font>).</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193132\" data-linked=\"Luck of the Irish: Jazz, Alkermes rally on deal speculation\" data-tweet=\"$PRGO $PRGO $JAZZ - Luck of the Irish: Jazz, Alkermes rally on deal speculation https://seekingalpha.com/news/1193132-luck-of-the-irish-jazz-alkermes-rally-on-deal-speculation?source=tweet\" data-url=\"https://seekingalpha.com/news/1193132-luck-of-the-irish-jazz-alkermes-rally-on-deal-speculation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193112\" data-ts=\"1375721550\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRIS\" target=\"_blank\">CRIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193112-curis-gains-on-a-solid-q2-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Curis gains on a solid Q2 report</a></h4><ul>\n<li>Curis (<a href=\"https://seekingalpha.com/symbol/CRIS\" title=\"Curis, Inc.\">CRIS</a> <font color=\"green\">+2.5%</font>) moves up after its <a href=\"https://seekingalpha.com/market_currents/post/1191962\" target=\"_blank\">Q2 easily topped estimates</a> this morning.</li>\n<li>Revenue grew by 25% Y/Y, primarily the result of an increase in royalties received from Genentech/Roche's net sales of Erivedge and its achievement of certain clinical objectives in its ongoing Phase 1 clinical study of CUDC-907.</li>\n<li>The company currently anticipates that it will end 2013 with around $49M to $54M in cash and equivalents, which includes the $6M milestone payment that it earned in July related to the conditional approval of Erivedge in the European Union.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193112\" data-linked=\"Curis gains on a solid Q2 report\" data-tweet=\"$CRIS - Curis gains on a solid Q2 report https://seekingalpha.com/news/1193112-curis-gains-on-a-solid-q2-report?source=tweet\" data-url=\"https://seekingalpha.com/news/1193112-curis-gains-on-a-solid-q2-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193092\" data-ts=\"1375721106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193092-midday-top-10-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers / Losers</a></h4><ul>     <li><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/SPEX' title='Spherix Incorporated'>SPEX</a> <font color='green'>+153%</font>. <a href='https://seekingalpha.com/symbol/MCOX' title='Mecox Lane Limited'>MCOX</a> <font color='green'>+98%</font>. <a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a> <font color='green'>+41%</font>. <a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a> <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/STXS' title='Stereotaxis, Inc.'>STXS</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/VIAS' title='Viasystems Group, Inc.'>VIAS</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/PULS-OLD' title='Pulse Electronics Corporation'>PULS-OLD</a> <font color='green'>+26%</font>. PTNT <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/DATE' title='Jiayuan.com International Ltd.'>DATE</a> <font color='green'>+20%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GSE' title='GSE Holding'>GSE</a> <font color='red'>-35%</font>. <a href='https://seekingalpha.com/symbol/KONE' title='Kingtone Wirelessinfo Solution Holding Ltd'>KONE</a> <font color='red'>-17%</font>. NTE <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/SNMX' title='Senomyx, Inc.'>SNMX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/MIG' title='Meadowbrook Insurance Group Inc.'>MIG</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CEMI' title='Chembio Diagnostics, Inc.'>CEMI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SSP' title='The E.W. Scripps Company'>SSP</a> <font color='red'>-10%</font>. BSDM <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/GIG' title='GigPeak, Inc.'>GIG</a> <font color='red'>-8%</font>. PBMD <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193092\" data-linked=\"Midday top 10 gainers / Losers\" data-tweet=\"$SPEX $MCOX $CGEN - Midday top 10 gainers / Losers https://seekingalpha.com/news/1193092-midday-top-10-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1193092-midday-top-10-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193072\" data-ts=\"1375720504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAN\" target=\"_blank\">UAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193072-cvr-partners-hits-52-week-low-following-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CVR Partners hits 52-week low following Q2 results</a></h4><ul>     <li>CVR Partners (<a href=\"https://seekingalpha.com/symbol/UAN\" title=\"CVR Partners, LP\">UAN</a> <font color=\"red\">-4.7%</font>) hits a 52-week low in an apparent delayed reaction to <a href=\"https://seekingalpha.com/currents/post/1184922\" target=\"_blank\">Q2 results</a> that included sharply lower FY 2013 guidance to reflect lower fertilizer prices available in H2 as well as the impact of an unexpected plant shutdown.</li>     <li>Blogger Chris Damas <a href=\"https://seekingalpha.com/article/1604362-cvr-partners-sees-soft-second-half\" target=\"_blank\">forecasts</a> a reduction in FY 2013 cash distributions from $2.15-$2.45/unit to $1.80-$1.90; since $1.19 was paid in H1, it would indicate a combined Q3-Q4 2013 distribution of $0.61-$0.81/unit.</li>     <li>Damas calculates CVR's Q3 ammonia production will come in at 96K tons vs. 104K a year ago.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1193072\" data-linked=\"CVR Partners hits 52-week low following Q2 results\" data-tweet=\"$UAN - CVR Partners hits 52-week low following Q2 results https://seekingalpha.com/news/1193072-cvr-partners-hits-52-week-low-following-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/1193072-cvr-partners-hits-52-week-low-following-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193062\" data-ts=\"1375720362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POR\" target=\"_blank\">POR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193062-porland-general-cut-to-neutral-at-da-davidson\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Porland General cut to Neutral at DA Davidson</a></h4><ul>\n<li>Portland General Electric (<a href=\"https://seekingalpha.com/symbol/POR\" title=\"Portland General Electric Company\">POR</a> <font color=\"red\">-1.1%</font>) hits new lows today after DA Davidson <a href=\"http://www.streetinsider.com/Downgrades/DA+Davidson+Downgrades+Portland+General+Electric+Company+%28POR%29+to+Neutral/8565916.html\" target=\"_blank\">cut the shares</a> from Buy to Neutral and lowers its price target from $35 to $33 on the back of weaker FY13 guidance.</li>\n<li>The northwest utility reported a Q2 loss on Friday and lowered its full-year 2013 earnings guidance to $1.25 to $1.40 per share, which is a $0.10 decrease from its earlier June 3 guidance revision of $1.35 to $1.50.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193062\" data-linked=\"Porland General cut to Neutral at DA Davidson\" data-tweet=\"$POR - Porland General cut to Neutral at DA Davidson https://seekingalpha.com/news/1193062-porland-general-cut-to-neutral-at-da-davidson?source=tweet\" data-url=\"https://seekingalpha.com/news/1193062-porland-general-cut-to-neutral-at-da-davidson\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193042\" data-ts=\"1375719804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/Z\" target=\"_blank\">Z</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193042-zillow-adds-to-gains-following-news-of-obama-event\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow adds to gains following news of Obama event</a></h4><ul>\n<li>Pres. Obama will answer housing-related questions during a 1PM ET Wednesday \"virtual housing roundtable discussion\" hosted by Zillow (<a href=\"https://seekingalpha.com/symbol/Z\" title=\"Zillow Group, Inc.\">Z</a> <font color=\"green\">+5.6%</font>), and moderated by CEO Spencer Rascoff.</li>\n<li> \"U.S. homeowners, renters and prospective buyers\" can ask questions via Facebook and Twitter.</li>\n<li>Zillow shares have added to the big gains they saw last week in response to Trulia's (TRLA <font color=\"green\">+6.4%</font>) <a href=\"https://seekingalpha.com/currents/post/1181352\" target=\"_blank\">Q2 report</a>. Trulia is also rallying to new post-IPO highs.</li>\n<li>Zillow's Q2 report arrives tomorrow.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193042\" data-linked=\"Zillow adds to gains following news of Obama event\" data-tweet=\"$Z - Zillow adds to gains following news of Obama event https://seekingalpha.com/news/1193042-zillow-adds-to-gains-following-news-of-obama-event?source=tweet\" data-url=\"https://seekingalpha.com/news/1193042-zillow-adds-to-gains-following-news-of-obama-event\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1193032\" data-ts=\"1375719729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENZ\" target=\"_blank\">ENZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1193032-federal-judge-upholds-48_6m-judgement-in-favor-of-enzo-biochem\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Federal Judge upholds $48.6M judgement in favor of Enzo Biochem</a></h4><ul>\n<li>Enzo Biochem (<a href=\"https://seekingalpha.com/symbol/ENZ\" title=\"Enzo Biochem, Inc.\">ENZ</a> <font color=\"green\">+8.6%</font>) jumps after a Federal Court Judge upholds the jury verdict issued in  November, 2012, which awarded the drug developer $48.6M in damages as a result of patent infringement by Applera Corporation, which is now Life Technologies (<a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a> <font color=\"red\">-0.1%</font>).</li>\n<li>The court ruled initially that <a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a> infringed on <a href=\"https://seekingalpha.com/symbol/ENZ\" title=\"Enzo Biochem, Inc.\">ENZ</a>'s patent covering pioneering technologies relating to compounds used in DNA sequencing systems to read genetic code.</li>\n<li>The Judge also denied <a href=\"https://seekingalpha.com/symbol/LIFE\" title=\"aTyr Pharma\">LIFE</a>'s request for a finding that Enzo's infringement claims are barred by laches and/or equitable estoppel and its motion for a new trial, as well as <a href=\"https://seekingalpha.com/symbol/ENZ\" title=\"Enzo Biochem, Inc.\">ENZ</a>'s request for reconsideration seeking additional damages.</li>\n<li>The ruling opens the way for <a href=\"https://seekingalpha.com/symbol/ENZ\" title=\"Enzo Biochem, Inc.\">ENZ</a> to recover prejudgment interest on the damages award, which should exceed $25M in addition to the judgment.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1193032\" data-linked=\"Federal Judge upholds $48.6M judgement in favor of Enzo Biochem\" data-tweet=\"$ENZ $ENZ $TMO - Federal Judge upholds $48.6M judgement in favor of Enzo Biochem https://seekingalpha.com/news/1193032-federal-judge-upholds-48_6m-judgement-in-favor-of-enzo-biochem?source=tweet\" data-url=\"https://seekingalpha.com/news/1193032-federal-judge-upholds-48_6m-judgement-in-favor-of-enzo-biochem\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192972\" data-ts=\"1375718967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHFS\" target=\"_blank\">CHFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192972-sunshine-heart-jumps-on-an-upbeat-report-from-runway-research\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunshine Heart jumps on an upbeat report from Runway Research</a></h4><ul>\n<li>Sunshine Heart (SSH <font color=\"green\">+17%</font>) pops on a report out of <a href=\"https://seekingalpha.com/instablog/12735661-runwayresearch/2097252-sunshine-heart-10-reasons-why-this-game-changing-cardio-device-company-could-be-acquired-for-50-share\" target=\"_blank\">Runway Research</a> saying the company's C-Pulse Heart Assist System is a \"game changing device\" that could lead to a buyout worth as much as $50 per share.</li>\n<li>SSH received unconditional FDA approval for the C-Pulse(NYSE:<a href=\"https://seekingalpha.com/symbol/R\" title=\"Ryder System, Inc.\">R</a>) system's U.S. pivotal trial in November, 2012.</li>\n<li>With the device, Runway says that SSH is targeting the New York Heart Association's Class III and ambulatory Class IV Congestive Heart Failure market, which is an enormous untapped opportunity with approximately 1.5M patients in the U.S. and another 3.7M patients in Europe.</li>\n<li>If the company penetrates just 10% of this market, the firm says the opportunity could reach over $5B.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1192972\" data-linked=\"Sunshine Heart jumps on an upbeat report from Runway Research\" data-tweet=\"$CHFS $CHFS $R - Sunshine Heart jumps on an upbeat report from Runway Research https://seekingalpha.com/news/1192972-sunshine-heart-jumps-on-an-upbeat-report-from-runway-research?source=tweet\" data-url=\"https://seekingalpha.com/news/1192972-sunshine-heart-jumps-on-an-upbeat-report-from-runway-research\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192932\" data-ts=\"1375718185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XPO\" target=\"_blank\">XPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192932-xpo-logistics-lower-after-filing-for-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XPO Logistics lower after filing for secondary offering</a></h4><ul> <li>Shares of XPO Logistics (<a href='https://seekingalpha.com/symbol/XPO' title='XPO Logistics, Inc'>XPO</a> <font color='red'>-5.4%</font>) trail off after the company announces a secondary offering of 8M shares of its common stock.</li> <li><a href=\"http://www.sec.gov/Archives/edgar/data/1166003/000119312513318118/d578227d424b5.htm\" target=\"_blank\">SEC filing</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"1192932\" data-linked=\"XPO Logistics lower after filing for secondary offering\" data-tweet=\"$XPO - XPO Logistics lower after filing for secondary offering https://seekingalpha.com/news/1192932-xpo-logistics-lower-after-filing-for-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/1192932-xpo-logistics-lower-after-filing-for-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192922\" data-ts=\"1375717792\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192922-cliffs-share-surge-on-bloom-lake-labor-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cliffs share surge on Bloom Lake labor agreement</a></h4><ul>     <li>Cliffs Natural Resources (<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a> <font color=\"green\">+4%</font>) rallies after <a href=\"https://seekingalpha.com/currents/post/1191202\" target=\"_blank\">Friday's news</a> that it had reached a tentative agreement with the United Steelworkers Union on a three-year labor contract covering about 300 workers at its Bloom Lake mine in Quebec.</li>\n<li>\n<a href=\"https://seekingalpha.com/currents/search?query=bloom+lake\" target=\"_blank\">Bloom Lake</a> is considered a key to CLF's future and has proven costly, but lower Q2 cash costs of $87/metric ton was down 4% Y/Y, mostly due to  improved production volumes and the resulting favorable impact on the  mine's cost rate.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1192922\" data-linked=\"Cliffs share surge on Bloom Lake labor agreement\" data-tweet=\"$CLF - Cliffs share surge on Bloom Lake labor agreement https://seekingalpha.com/news/1192922-cliffs-share-surge-on-bloom-lake-labor-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/1192922-cliffs-share-surge-on-bloom-lake-labor-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192902\" data-ts=\"1375717312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYD\" target=\"_blank\">CYD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192902-china-yuchai-posts-a-solid-q2-shares-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">China Yuchai posts a solid Q2; shares higher</a></h4><ul>\n<li>China Yuchai (<a href=\"https://seekingalpha.com/symbol/CYD\" title=\"China Yuchai International Limited\">CYD</a> <font color=\"green\">+8.4%</font>) trades up after <a href=\"https://seekingalpha.com/market_currents/post/1191862\" target=\"_blank\">easily beating Q2 estimates</a> this morning.</li>\n<li>Net revenue rose 23.9% Y/Y. Operating profit was RMB 333.8B, +59% from the prior year as gross profit largely offset a gain in operating expenses.</li>\n<li>Total number of engines rose by 29%, totaling 141,147 units compared with 109,329 units in Q212.</li>\n<li>The company attributes the volume gain to an increase in sales of engines for agriculture and truck applications, and and higher sales of commercial vehicles due to the pre-buying of trucks prior to the implementation of the National IV emission standards that went into effect nationwide on July 1.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1192902\" data-linked=\"China Yuchai posts a solid Q2; shares higher\" data-tweet=\"$CYD - China Yuchai posts a solid Q2; shares higher https://seekingalpha.com/news/1192902-china-yuchai-posts-a-solid-q2-shares-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1192902-china-yuchai-posts-a-solid-q2-shares-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192882\" data-ts=\"1375716719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PACB\" target=\"_blank\">PACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192882-pacific-biosciences-extends-post-earnings-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Biosciences extends post-earnings rally</a></h4><ul>     <li>Pacific Biosciences (<a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a> <font color='green'>+13%</font>) rallies for a third consecutive session.</li>     <li>The shares are now up <font color='green'>~24%</font> since last Thursday. (see <a href=\"https://seekingalpha.com/currents/post/1187492\" target=\"_blank\">Q2 earnings</a>)</li>     <li>Piper <a href=\"https://seekingalpha.com/currents/post/1191062\" target=\"_blank\">upgraded the shares</a> Friday citing a \"renewed sense of stability.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192882\" data-linked=\"Pacific Biosciences extends post-earnings rally\" data-tweet=\"$PACB - Pacific Biosciences extends post-earnings rally https://seekingalpha.com/news/1192882-pacific-biosciences-extends-post-earnings-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/1192882-pacific-biosciences-extends-post-earnings-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192862\" data-ts=\"1375716392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMN\" target=\"_blank\">AMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192862-amn-healthcare-raised-to-neutral-at-ubs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMN Healthcare raised to Neutral at UBS</a></h4><ul>\n<li>AMN Healthcare Services (AHS <font color=\"green\">+9.8%</font>) gets a big boost from an <a href=\"http://www.streetinsider.com/Upgrades/UBS+Upgrades+AMN+Healthcare+Services+%28AHS%29+to+Neutral/8565323.html\" target=\"_blank\">upgrade to Neutral</a> from Sell at UBS.  The firm also raises its price target to $16 from $9.</li>\n<li>UBS says that despite an uneven turn around in the medical staffing sector, the company has continued to post solid numbers.</li>\n<li>Additionally, problems at its largest competitor, Cross Country Healthcare (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CCRN\" title=\"Cross Country Healthcare, Inc.\">CCRN</a>), have created an opportunity for AHS to gain market share.</li>\n<li>The new $16 target is based on a multiple of roughly 20x UBS' 2014 EPS estimate, reflecting increased confidence AHS will continue to meet targets despite a challenging macro backdrop.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1192862\" data-linked=\"AMN Healthcare raised to Neutral at UBS\" data-tweet=\"$AMN $AMN $CCRN - AMN Healthcare raised to Neutral at UBS https://seekingalpha.com/news/1192862-amn-healthcare-raised-to-neutral-at-ubs?source=tweet\" data-url=\"https://seekingalpha.com/news/1192862-amn-healthcare-raised-to-neutral-at-ubs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192852\" data-ts=\"1375715737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSE\" target=\"_blank\">GSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192852-gse-holding-plunges-on-heavy-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSE Holding plunges on heavy volume</a></h4><ul><li>Shares of GSE Holding (<a href='https://seekingalpha.com/symbol/GSE' title='GSE Holding'>GSE</a> <font color='red'>-34.7%</font>) are sharply lower in morning trading.</li><li>Around 700K shares have already traded hands versus 10-day average volume of just ~74K.</li><li>CJS Securities <a href=\"http://www.streetinsider.com/Downgrades/CJS+Securities+Downgrades+GSE+Holdings+%28GSE%29+to+Market+Perform/8565704.html\" target=\"_blank\">downgrades the stock</a> to Market Perform from Outperform.</li></ul><div class=\"tiny-share-widget\" data-id=\"1192852\" data-linked=\"GSE Holding plunges on heavy volume\" data-tweet=\"$GSE - GSE Holding plunges on heavy volume https://seekingalpha.com/news/1192852-gse-holding-plunges-on-heavy-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/1192852-gse-holding-plunges-on-heavy-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192842\" data-ts=\"1375715446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAIL\" target=\"_blank\">RAIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192842-big-order-for-q3-lifts-freightcar-america\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big order for Q3 lifts FreightCar America</a></h4><ul> <li>FreightCar America (<a href='https://seekingalpha.com/symbol/RAIL' title='FreightCar America, Inc.'>RAIL</a> <font color='green'>+8.7%</font>) pops after <a href=\"https://seekingalpha.com/currents/post/1191892\" target=\"_blank\">Q2 results</a> came in off-target, but the company reported a large order which will tip the scales back in its favor.</li> <li>Orders for over 5.5K railcars were received after June 30, inclusive of orders for about 4K rebuilt coal cars to serve the Eastern coal market.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1192842\" data-linked=\"Big order for Q3 lifts FreightCar America\" data-tweet=\"$RAIL - Big order for Q3 lifts FreightCar America https://seekingalpha.com/news/1192842-big-order-for-q3-lifts-freightcar-america?source=tweet\" data-url=\"https://seekingalpha.com/news/1192842-big-order-for-q3-lifts-freightcar-america\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192832\" data-ts=\"1375715426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVL\" target=\"_blank\">AVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192832-avalon-may-be-on-track-to-build-canadas-first-rare-earth-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avalon may be on track to build Canada&#39;s first rare earth mine</a></h4><ul>     <li>Avalon Rare Metals (<a href=\"https://seekingalpha.com/symbol/AVL\" title=\"Avalon Rare Metals Inc.\">AVL</a> <font color=\"green\">+9.9%</font>) shoots higher on a report suggesting it <a href=\"http://rareearthinvestingnews.com/13961-is-avalon-on-track-to-build-canadas-first-rare-earth-mine.html\" target=\"_blank\">could build Canada's first rare earth mine</a>, based on a stream of news recently released by AVL about its Nechalacho Rare Earth Elements Project at Thor Lake, Northwest Territories.</li>     <li>The news, as well as rising rare earth prices, have contributed to recent bullishness on AVL; \"Investors would do well to keep Avalon  on their watch list of companies considered to have the potential to  turn rare earth deposits into mines.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192832\" data-linked=\"Avalon may be on track to build Canada&#39;s first rare earth mine\" data-tweet=\"$AVL $AVLNF - Avalon may be on track to build Canada&#39;s first rare earth mine https://seekingalpha.com/news/1192832-avalon-may-be-on-track-to-build-canadas-first-rare-earth-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/1192832-avalon-may-be-on-track-to-build-canadas-first-rare-earth-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192822\" data-ts=\"1375715043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192822-facebook-tops-39-as-piper-hikes-pt-to-46\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook tops $39 as Piper hikes PT to $46</a></h4><ul>     <li>Gene Munster (of <a href=\"https://seekingalpha.com/currents/search?query=aapl%20munster\" target=\"_blank\">Apple fame</a>) is raising hit PT to $46 from $38. He's upbeat about the potential of new Facebook (<a href=\"https://seekingalpha.com/symbol/FB\" title=\"Facebook\">FB</a> <font color=\"green\">+3.2%</font>) ad products, including <a href=\"https://seekingalpha.com/currents/post/1175652\" target=\"_blank\">video ads</a>, graph search ads, and (in 2015 or later) Instagram ads.</li>     <li>Shares <strong><font color=\"green\">+48%</font></strong> since the <a href=\"https://seekingalpha.com/currents/post/1158952\" target=\"_blank\">Q2 beat</a>.</li>     <li>Previous: <a href=\"https://seekingalpha.com/currents/post/1192452\" target=\"_blank\">Facebook hires first CMO<br>     </a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192822\" data-linked=\"Facebook tops $39 as Piper hikes PT to $46\" data-tweet=\"$FB - Facebook tops $39 as Piper hikes PT to $46 https://seekingalpha.com/news/1192822-facebook-tops-39-as-piper-hikes-pt-to-46?source=tweet\" data-url=\"https://seekingalpha.com/news/1192822-facebook-tops-39-as-piper-hikes-pt-to-46\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192792\" data-ts=\"1375714933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNSN\" target=\"_blank\">HNSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192792-hansen-medical-enrolls-the-first-patients-robotic-catheter-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hansen Medical enrolls the first patients robotic catheter trial</a></h4><ul>\n<li>Hansen Medical (<a href=\"https://seekingalpha.com/symbol/HNSN\" title=\"Hansen Medical, Inc.\">HNSN</a> <font color=\"green\">+11%</font>) pops after announcing the first patients have been enrolled in its Artisan-AF Trial, a test of the company's Artisan family of Control Catheters with its Sensei X Robotic Catheter System for the treatment of atrial fibrillation.</li>\n<li>The Company announced in May that it had received conditional approval of the new study design from the FDA, and is targeting the enrollment of as few as 125 subjects at up to 14 investigational sites.</li>\n<li>It plans to use the data derived from the study to obtain approval for a broader label claim for use of its control catheters in tandem with its Sensei X Robotic Catheter System in atrial fibrillation procedures.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1192792\" data-linked=\"Hansen Medical enrolls the first patients robotic catheter trial\" data-tweet=\"$HNSN - Hansen Medical enrolls the first patients robotic catheter trial https://seekingalpha.com/news/1192792-hansen-medical-enrolls-the-first-patients-robotic-catheter-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/1192792-hansen-medical-enrolls-the-first-patients-robotic-catheter-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192762\" data-ts=\"1375714240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192762-blackberry-rallying-possibly-due-to-image-leaks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry rallying, possibly due to image leaks</a></h4><ul>     <li>BlackBerry (BBRY <font color=\"green\">+5.8%</font>) is up strongly on a fairly quiet day for tech stocks.</li>     <li>\n<a href=\"http://www.bberryblog.com/surge-el-rumor-de-un-nuevo-dispositivo-slider-llamado-blackberry-z15/\" target=\"_blank\">Images have leaked</a> of the BlackBerry Z15, a BB10 device with a slide-out keyboard.</li>\n<li>Also, <a href=\"http://crackberry.com/some-more-blackberry-z30-imagery-whet-your-appetite-new-blackberry-10-smartphone\" target=\"_blank\">new images</a> of BlackBerry's Z10 successor, 5\" display and all, have surfaced. <a href=\"https://seekingalpha.com/currents/post/1140372\" target=\"_blank\">Previously</a> referred to as the A10, the phone is now called the Z30.</li>     <li>Separately, <a href=\"https://twitter.com/thenotablecalls/status/364386961869385730\" target=\"_blank\">Notable Calls</a> reports hearing of \"buy-side talk\" about Q10 sell-outs.</li>     <li>Shares still <font color=\"red\">-35%</font> from where they traded prior to BlackBerry's <a href=\"https://seekingalpha.com/currents/post/1111632\" target=\"_blank\">FQ1 miss</a>.</li>\n<li>38% of the float was shorted as of July 15, and many of those shorts now have huge paper profits.</li>\n<li>\n<strong>Update:</strong> <a href=\"http://crackberry.com/blackberry-z15\" target=\"_blank\">CrackBerry says</a> the Z15 images are \"a confirmed concept.\" BlackBerry did <a href=\"http://www.engadget.com/2013/04/23/blackberry-awarded-design-patent-for-portrait-qwerty-slider/?utm_medium=feed&amp;utm_source=Feed_Classic&amp;utm_campaign=Engadget\" target=\"_blank\">obtain a patent</a> for a QWERTY slider phone in April.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192762\" data-linked=\"BlackBerry rallying, possibly due to image leaks\" data-tweet=\"$BB - BlackBerry rallying, possibly due to image leaks https://seekingalpha.com/news/1192762-blackberry-rallying-possibly-due-to-image-leaks?source=tweet\" data-url=\"https://seekingalpha.com/news/1192762-blackberry-rallying-possibly-due-to-image-leaks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192712\" data-ts=\"1375713203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MIG\" target=\"_blank\">MIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192712-meadowbrook-insurance-dives-on-a-m-best-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Meadowbrook Insurance dives on A.M. Best downgrade</a></h4><ul>\n<li>Shares of Meadowbrook Insurance (<a href=\"https://seekingalpha.com/symbol/MIG\" title=\"Meadowbrook Insurance Group Inc.\">MIG</a> <font color=\"red\">-9.8%</font>) sink following an <a href=\"http://www.marketwatch.com/story/am-best-downgrades-ratings-of-meadowbrook-insurance-group-inc-and-its-subsidiaries-2013-08-02\" target=\"_blank\">A.M. Best downgrade</a> to B++ (from A-).</li>\n<li>The insurance ratings group cites MIG's \"weaker than anticipated\" <a href=\"https://seekingalpha.com/currents/post/1177402\" target=\"_blank\">Q2 results</a>.</li>\n<li>MIG CEO Robert Cubbin is \"very disappointed\" with the decision and notes that the company has demonstrated \"progress towards [its] goal of a return to stable and profitable underwriting results.\" (PR)</li>\n<li>Over the weekend, the company secured an agreement with State National (an 'A' rated policy issuance company) which meets MIG's \"immediate needs\" in terms of programs and specialty divisions \"where an 'A' rated policy issuer is required.\" (PR)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1192712\" data-linked=\"Meadowbrook Insurance dives on A.M. Best downgrade\" data-tweet=\"$MIG - Meadowbrook Insurance dives on A.M. Best downgrade https://seekingalpha.com/news/1192712-meadowbrook-insurance-dives-on-a-m-best-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/1192712-meadowbrook-insurance-dives-on-a-m-best-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192702\" data-ts=\"1375713086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192702-a-roundup-of-tech-analyst-ratings-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech analyst ratings changes</a></h4><ul>\n<li>Qualcomm (<a href=\"https://seekingalpha.com/symbol/QCOM\" title=\"Qualcomm Inc.\">QCOM</a> <font color=\"red\">-1.7%</font>) has been cut to Neutral by Piper.</li>\n<li>Canadian Solar (<a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"green\">+9.7%</font>) fresh off <a href=\"https://seekingalpha.com/currents/post/1192242\" target=\"_blank\">selling 5 solar plants</a>, has been started at Buy by Roth.</li>\n<li>Riverbed (<a href=\"https://seekingalpha.com/symbol/RVBD\" title=\"Riverbed Technology, Inc.\">RVBD</a> <font color=\"green\">+3.2%</font>) has been upgraded to Outperform by Oppenheimer less than a week after plunging on account of <a href=\"https://seekingalpha.com/currents/post/1175842\" target=\"_blank\">missing</a> Q2 revenue estimates and issuing <a href=\"https://seekingalpha.com/currents/post/1177082\" target=\"_blank\">light guidance</a>.</li>\n<li>Broadcom (BRCM <font color=\"green\">+0.6%</font>) has been upgraded to Buy by Drexel Hamilton. Many other firms have been <a href=\"https://seekingalpha.com/currents/post/1158082\" target=\"_blank\">going in the opposite direction</a>.</li>\n<li>Perficient (<a href=\"https://seekingalpha.com/symbol/PRFT\" title=\"Perficient, Inc.\">PRFT</a> <font color=\"green\">+7.9%</font>) has been started at Buy by Needham in the wake of its Thursday <a href=\"https://seekingalpha.com/currents/post/1184402\" target=\"_blank\">Q2 beat</a>.</li>\n<li>MicroStrategy (<a href=\"https://seekingalpha.com/symbol/MSTR\" title=\"MicroStrategy Incorporated\">MSTR</a> <font color=\"green\">+1.6%</font>) has been upgraded to Buy by Roth a week after posting a <a href=\"https://seekingalpha.com/currents/post/1172802\" target=\"_blank\">Q2 miss</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1192702\" data-linked=\"A roundup of tech analyst ratings changes\" data-tweet=\"$QCOM $QCOM $CSIQ - A roundup of tech analyst ratings changes https://seekingalpha.com/news/1192702-a-roundup-of-tech-analyst-ratings-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/1192702-a-roundup-of-tech-analyst-ratings-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192682\" data-ts=\"1375712176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDCC\" target=\"_blank\">IDCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192682-interdigital-acacia-slump-following-white-house-itc-veto\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterDigital, Acacia slump following White House ITC veto</a></h4><ul>\n<li>Over the weekend, the Obama administration <a href=\"https://seekingalpha.com/currents/post/1191852\" target=\"_blank\">vetoed</a> a pending ITC ban on older iPhones and iPads <a href=\"https://seekingalpha.com/currents/post/1064511\" target=\"_blank\">ruled to be infringing</a> standards-essential Samsung IP. InterDigital (<a href=\"https://seekingalpha.com/symbol/IDCC\" title=\"InterDigital, Inc.\">IDCC</a> <font color=\"red\">-10.1%</font>) and Acacia (<a href=\"https://seekingalpha.com/symbol/ACTG\" title=\"Acacia Research Corporation\">ACTG</a> <font color=\"red\">-2.5%</font>) shares are selling off today, apparently on concerns about <a href=\"http://online.wsj.com/article/SB10001424127887323420604578648272862276836.html\" target=\"_blank\">the ruling's impact</a> for the companies' own ITC infringement suits (<a href=\"https://seekingalpha.com/currents/post/1113332\" target=\"_blank\">I</a>, <a href=\"http://essentialpatentblog.com/2013/01/acacia-research-subsidiary-adaptix-files-new-itc-complaint-accusing-ericsson-of-infringing-4g-lte-essential-patent/\" target=\"_blank\">II</a>).</li>\n<li>In justifying the veto, U.S. trade rep. Michael Froman said he \"strongly shares\" concerns raised by the DOJ and USPTO about ITC bans being issued in cases involving standards-essential patents.</li>\n<li>In June, <a href=\"https://seekingalpha.com/currents/post/1066471\" target=\"_blank\">the White House announced</a> 5 executive actions and 7 legislative proposals meant to limit the power of perceived patent trolls, and FTC chairwoman Edith Ramirez <a href=\"https://seekingalpha.com/currents/post/1096772\" target=\"_blank\">followed up</a> by requesting a major investigation of their behavior.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1192682\" data-linked=\"InterDigital, Acacia slump following White House ITC veto\" data-tweet=\"$IDCC $IDCC $ACTG - InterDigital, Acacia slump following White House ITC veto https://seekingalpha.com/news/1192682-interdigital-acacia-slump-following-white-house-itc-veto?source=tweet\" data-url=\"https://seekingalpha.com/news/1192682-interdigital-acacia-slump-following-white-house-itc-veto\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192612\" data-ts=\"1375711082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JASO\" target=\"_blank\">JASO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192612-ja-solar-obtains-90m-credit-facility-from-state-bank-shares-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JA Solar obtains $90M credit facility from state bank, shares higher</a></h4><ul>\n<li>JA Solar (<a href=\"https://seekingalpha.com/symbol/JASO\" title=\"JA Solar Holdings, Co., Ltd.\">JASO</a> <font color=\"green\">+6.2%</font>) and \"related party\" Jinglong Group have obtained an RMB550M ($90M) credit facility from the state-owned Bank of Communications of China. JA only says it plans to use the proceeds for \"working capital and general corporate purposes.\"</li>\n<li>JA had $882M in debt on its balance sheet at the end of Q1, and $503M in cash/investments.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"1192612\" data-linked=\"JA Solar obtains $90M credit facility from state bank, shares higher\" data-tweet=\"$JASO - JA Solar obtains $90M credit facility from state bank, shares higher https://seekingalpha.com/news/1192612-ja-solar-obtains-90m-credit-facility-from-state-bank-shares-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/1192612-ja-solar-obtains-90m-credit-facility-from-state-bank-shares-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192572\" data-ts=\"1375710338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLRX\" target=\"_blank\">BLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192572-biolinerxs-blminus-8040-treatment-effective-in-pre-clinical-trials\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLineRx&#39;s BL-8040 treatment effective in pre-clinical trials</a></h4><ul>     <li>BioLineRx's (<a href=\"https://seekingalpha.com/symbol/BLRX\" title=\"BioLineRx Ltd.\">BLRX</a> <font color=\"green\">+1.6%</font>) BL-8040 drug was effective in treating thrombocytopenia, or reduced platelet production, in pre-clinical trials of healthy mice as well as those with chemotherapy induced-thrombocytopenic.</li>     <li>\"BL-8040 significantly increased the number of megakaryocytes (cells that produce platelets) within the bone marrow,\" BioLineRx says. \"This was associated with increased production and increased levels of platelets in the blood\" in both types of mice.</li>     <li>BL-8040 also increased the number of hematopoietic progenitor cells within the bone marrow and in the blood. These are important for generating \"the whole gamut of red and white blood cells.\"</li>     <li>BL-8040 cut the severity and duration of chemotherapy-induced thrombocytopenia and cytopenia.</li>     <li>BioLineRx is developing BL-8040 for acute myeloid leukemia, for which the drug is undergoing Phase II trials. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192572\" data-linked=\"BioLineRx&#39;s BL-8040 treatment effective in pre-clinical trials\" data-tweet=\"$BLRX - BioLineRx&#39;s BL-8040 treatment effective in pre-clinical trials https://seekingalpha.com/news/1192572-biolinerxs-blminus-8040-treatment-effective-in-pre-clinical-trials?source=tweet\" data-url=\"https://seekingalpha.com/news/1192572-biolinerxs-blminus-8040-treatment-effective-in-pre-clinical-trials\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192492\" data-ts=\"1375708885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192492-vringo-keeps-soaring-following-supplemental-damages-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vringo keeps soaring following supplemental damages ruling</a></h4><ul>     <li>Vringo (VRNG) <font color=\"green\">+11.6%</font> premarket, adding to Friday's 10% gain, as investors continue weighing a <a href=\"https://seekingalpha.com/currents/post/1191072\" target=\"_blank\">Friday ruling</a> the company is entitled to <a href=\"http://breakingfinancenews.com/headlines/vringo-shares-will-likely-add-to-fridays-huge-gain-heres-why-vrng/2274/\" target=\"_blank\">supplemental damages</a> (as well as pre-judgment and post-judgment interest) for a Nov. '12 infringement ruling in its IP suit against Google, AOL, and others.</li>     <li>Interest will be calculated based on the prime rate for U.S. treasuries. Vringo has been asked to submit its estimated damage amounts, after which defendants will have a chance to respond.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192492\" data-linked=\"Vringo keeps soaring following supplemental damages ruling\" data-tweet=\"$XSPA - Vringo keeps soaring following supplemental damages ruling https://seekingalpha.com/news/1192492-vringo-keeps-soaring-following-supplemental-damages-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/1192492-vringo-keeps-soaring-following-supplemental-damages-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192462\" data-ts=\"1375708553\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGYP\" target=\"_blank\">SGYP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192462-synergy-to-initiate-phase-3-plecanatide-cic-trial-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synergy to initiate Phase 3 plecanatide CIC trial in Q4</a></h4><ul>     <li>Synergy Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SGYP\" title=\"Synergy Pharmaceuticals, Inc.\">SGYP</a>) completes an end-of-Phase 2 meeting with the FDA regarding <a href=\"https://seekingalpha.com/currents/search?query=plecanatide\" target=\"_blank\">plecanatide</a> for the treatment of       chronic idiopathic constipation.</li>     <li>The company and the regulator reach an agreement on the requirements and specifications for a Phase 3 pivotal program which will begin in Q4. (PR)</li>     <li>Shares <font color=\"green\">+3.26%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192462\" data-linked=\"Synergy to initiate Phase 3 plecanatide CIC trial in Q4\" data-tweet=\"$SGYP $SGYP-OLD - Synergy to initiate Phase 3 plecanatide CIC trial in Q4 https://seekingalpha.com/news/1192462-synergy-to-initiate-phase-3-plecanatide-cic-trial-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/1192462-synergy-to-initiate-phase-3-plecanatide-cic-trial-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192472\" data-ts=\"1375708517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEZ\" target=\"_blank\">FEZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192472-market-preview-stock-futures-taking-a-breather\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market Preview: Stock futures taking a breather</a></h4><ul>     <li>\n<b>Market preview:</b> <a href=\"http://online.wsj.com/article/SB10001424127887323514404578649531615246680.html\" target=\"_blank\">U.S. stock futures</a> are lower after shares closed at record highs on Friday following weaker-than-expected employment data.</li>     <li>The S&amp;P Mini is <font color=\"red\">-0.15%</font>.</li>     <li>\"After the rally we've just had, there's no need to chase\" gains, says Michael O'Rourke, chief market strategist for JonesTrading.  \"People didn't know how to interpret the jobs report,\" so investors are looking to \"see where (benchmarks) settle, and from there, evaluate and decide whether (they) want to be more aggressive.\"</li>     <li>European shares (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/FEZ\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a>) are mixed despite more encouraging PMI data, this time in the services sector.</li>     <li>Following earnings, Tyson Foods is <font color=\"green\">+4.35%</font> but HSBC is <font color=\"red\">-5%</font>.</li>     <li>\n<a href=\"https://seekingalpha.com/currents/post/1191592\" target=\"_blank\">Later</a>: ISM Non-Manufacturing Index</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192472\" data-linked=\"Market Preview: Stock futures taking a breather\" data-tweet=\"$FEZ - Market Preview: Stock futures taking a breather https://seekingalpha.com/news/1192472-market-preview-stock-futures-taking-a-breather?source=tweet\" data-url=\"https://seekingalpha.com/news/1192472-market-preview-stock-futures-taking-a-breather\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192432\" data-ts=\"1375708176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192432-premarket-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers / losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a> <font color='green'>+57%</font>. <a href='https://seekingalpha.com/symbol/SPEX' title='Spherix Incorporated'>SPEX</a> <font color='green'>+25%</font>. VRNG <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TGX' title='Theragenics Corporation'>TGX</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a> <font color='green'>+5%</font>.<br><b>Losers:</b> PBMD <font color='red'>-12%</font>. HBC <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192432\" data-linked=\"Premarket gainers / losers\" data-tweet=\"$CGEN $SPEX $XSPA - Premarket gainers / losers https://seekingalpha.com/news/1192432-premarket-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/1192432-premarket-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192342\" data-ts=\"1375707160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGEN\" target=\"_blank\">CGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192342-compugen-signs-development-deal-with-bayer-shares-soar\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Compugen signs development deal with Bayer; shares soar</a></h4><ul>   <li>Compugen (<a href=\"https://seekingalpha.com/symbol/CGEN\" title=\"Compugen Ltd.\">CGEN</a> <font color=\"green\">+58%</font>) rockets higher after signing a deal with Bayer HealthCare (<a href=\"https://seekingalpha.com/symbol/BAYZF\" title=\"Bayer A.G.\">OTCPK:BAYZF</a>) for two projects to develop antibody-based immunotherapies for cancer</li>    <li>Under the deal, Bayer will get worldwide commercialization rights for any treatments that are produced.</li>    <li>Compugen will receive $10M upfront and over $530M in milestones, as well as mid-high single-digit royalties on sales of any products.</li>    <li>Antibody-based immunotherapies are designed to stimulate the body's immune cells to fight cancer. (PR)</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192342\" data-linked=\"Compugen signs development deal with Bayer; shares soar\" data-tweet=\"$CGEN $CGEN $BAYZF - Compugen signs development deal with Bayer; shares soar https://seekingalpha.com/news/1192342-compugen-signs-development-deal-with-bayer-shares-soar?source=tweet\" data-url=\"https://seekingalpha.com/news/1192342-compugen-signs-development-deal-with-bayer-shares-soar\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192332\" data-ts=\"1375707080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOO\" target=\"_blank\">SHOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192332-steve-madden-gets-two-notch-upgrade-at-goldman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steve Madden gets two-notch upgrade at Goldman</a></h4><ul>     <li>Goldman <a href=\"http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Steven+Madden+%28SHOO%29+from+Sell+to+Buy/8564718.html\" target=\"_blank\">upgrades</a> Steve Madden (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHOO\" title=\"Steven Madden, Ltd.\">SHOO</a>) from Sell to Buy and raises the price target on the shares to $69 from $43.</li>     <li>Analyst Taposh Bari says the company's balance sheet is \"overcapitalized [and]  now has 1.3x net cash/EBITDA\" which could mean \"more meaningful buybacks, dividends, and/or M&amp;A.\"</li>     <li>Shares <font color=\"green\">+3.7%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192332\" data-linked=\"Steve Madden gets two-notch upgrade at Goldman\" data-tweet=\"$SHOO - Steve Madden gets two-notch upgrade at Goldman https://seekingalpha.com/news/1192332-steve-madden-gets-two-notch-upgrade-at-goldman?source=tweet\" data-url=\"https://seekingalpha.com/news/1192332-steve-madden-gets-two-notch-upgrade-at-goldman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192272\" data-ts=\"1375705889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMCR\" target=\"_blank\">GMCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192272-green-mountain-coffee-roasters-lower-after-barrons-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Mountain Coffee Roasters lower after Barron&#39;s warning</a></h4><ul> <li>Shares of Green Mountain Coffee Roasters (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GMCR\" title=\"Keurig Green Mountain Inc\">GMCR</a>) are <font color=\"red\">down 1%</font> in premarket trading after a <a href=\"https://seekingalpha.com/currents/post/1191442\" target=\"_blank\">harsh take</a> from <i>Barron's</i> pitched the case that the company's K-Cup market share is at risk of slipping and valuation could be worrisome.</li> <li>Things get even more interesting on GMCR later this week with FQ3 earnings due out on Wednesday.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"1192272\" data-linked=\"Green Mountain Coffee Roasters lower after Barron&#39;s warning\" data-tweet=\"$GMCR - Green Mountain Coffee Roasters lower after Barron&#39;s warning https://seekingalpha.com/news/1192272-green-mountain-coffee-roasters-lower-after-barrons-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/1192272-green-mountain-coffee-roasters-lower-after-barrons-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192242\" data-ts=\"1375705371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192242-canadian-solar-sells-five-solar-plants-for-290m-shares-plus-3_7-percent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Solar sells five solar plants for $290M, shares +3.7%</a></h4><ul>     <li>Canadian Solar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a>) agrees to sell five utility-scale solar power plants in Ontario totaling 49 mw valued at ~C$290M ($277M) to Concord Green Energy.</li>     <li>CSIQ will provide turnkey engineering, procurement and construction services to complete the projects and will provide operations and maintenance services after completion.</li>     <li>Shares <font color=\"green\">+3.7%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192242\" data-linked=\"Canadian Solar sells five solar plants for $290M, shares +3.7%\" data-tweet=\"$CSIQ - Canadian Solar sells five solar plants for $290M, shares +3.7% https://seekingalpha.com/news/1192242-canadian-solar-sells-five-solar-plants-for-290m-shares-plus-3_7-percent?source=tweet\" data-url=\"https://seekingalpha.com/news/1192242-canadian-solar-sells-five-solar-plants-for-290m-shares-plus-3_7-percent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192142\" data-ts=\"1375704070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKNG\" target=\"_blank\">BKNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192142-priceline-com-tapped-to-see-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Priceline.com tapped to see gains</a></h4><ul>     <li>JPMorgan <a href=\"https://twitter.com/WSConsensus/status/364350126954778627\" target=\"_blank\">raises</a> its price target on Priceline.com (PCLN) by 25% to $1,040 after adding in the impact from the acquisition of Kayak.</li>     <li>The investment firm sees a solid Q2 to be reported on this week from Priceline.com and more market share gains in the future.</li>     <li>PCLN <font color=\"green\">+1.1%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192142\" data-linked=\"Priceline.com tapped to see gains\" data-tweet=\"$BKNG - Priceline.com tapped to see gains https://seekingalpha.com/news/1192142-priceline-com-tapped-to-see-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/1192142-priceline-com-tapped-to-see-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192112\" data-ts=\"1375703058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQNM\" target=\"_blank\">SQNM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192112-new-york-issues-lab-permit-for-sequenom-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New York issues lab permit for Sequenom test</a></h4><ul>     <li>The New York Department of Health's Wadsworth Center Clinical Laboratory Evaluation Program issues a laboratory permit clearing the way for Sequenom (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SQNM\" title=\"Sequenom, Inc.\">SQNM</a>) to begin providing the state's healthcare professionals with the MaterniT21 PLUS test.</li>     <li>In other company news, SQNM's North Carolina lab gets accreditation from the College of American Pathologists. (PR)<br>     </li>     <li>Shares <font color=\"green\">+3%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192112\" data-linked=\"New York issues lab permit for Sequenom test\" data-tweet=\"$SQNM - New York issues lab permit for Sequenom test https://seekingalpha.com/news/1192112-new-york-issues-lab-permit-for-sequenom-test?source=tweet\" data-url=\"https://seekingalpha.com/news/1192112-new-york-issues-lab-permit-for-sequenom-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1192102\" data-ts=\"1375702950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSN\" target=\"_blank\">TSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1192102-strong-quarter-for-tyson-foods\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Strong quarter for Tyson Foods</a></h4><ul> <li>Consistent growth across segments led to a stellar quarter for Tyson Foods (NYSE:<a href=\"https://seekingalpha.com/symbol/TSN\" title=\"Tyson Foods Inc.\">TSN</a>) as demand was strong and protein prices cycled higher.</li> <li>The company recorded an operating margin of 7% in its Chicken segment and 3.1% for Beef.</li> <li>For FY13, Tyson expects to see $34.5B in sales.</li> <li>TSN <font color=\"green\">+4.4%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"1192102\" data-linked=\"Strong quarter for Tyson Foods\" data-tweet=\"$TSN - Strong quarter for Tyson Foods https://seekingalpha.com/news/1192102-strong-quarter-for-tyson-foods?source=tweet\" data-url=\"https://seekingalpha.com/news/1192102-strong-quarter-for-tyson-foods\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}